Two commonly used psychiatric drugs show evidence of improving symptoms of Alzheimer’s disease including boosting cognition, according to a study from researchers at the University of Colorado Anschutz Medical Campus.
Related Articles
News
Manufacturing roundup: AGC Biologics to manufacture diabetes therapy; Cambrex caps acquisition of Snapdragon Chemistry
January 26, 2023
UCBN
News
Comments Off on Manufacturing roundup: AGC Biologics to manufacture diabetes therapy; Cambrex caps acquisition of Snapdragon Chemistry
The Washington-based CDMO AGC Biologics has been tapped to manufacture the type 1 diabetes treatment Tzield from Provention Bio. AGC Biologics will produce Tzield at its Seattle protein biologics site. It was chosen after AGC […]
News
Enliven Therapeutics Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
December 11, 2025
UCBN
News, Syndication
Comments Off on Enliven Therapeutics Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
BOULDER, Colo., Dec. 11, 2025 /PRNewswire/ — Enliven Therapeutics, Inc. (“Enliven”), (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced that on December 11, 2025, Enliven […]
News
Can the ‘Dopamine Detox’ Trend Break My Digital Addiction?
January 20, 2024
UCBN
News, Syndication
Comments Off on Can the ‘Dopamine Detox’ Trend Break My Digital Addiction?
No podcasts, videos, or Netflix. No junk food, gambling or porn. Video gaming? No way. Instagram? Forget it. Music? Nope. Lock up your phone and hide your earbuds. It’s dopamine detox time, and it’s going […]
